Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas P Restifo

Showing results (171-180 of 260) with videos related to

Pageof 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccinesFranz O Smith, Stephanie G Downey, Jacob A Klapper, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2008
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunityDouglas C Palmer, Chi-Chao Chan, Luca Gattinoni, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2004
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cellsChristopher A Klebanoff, Steven E Finkelstein, Deborah R Surman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 15, 2006
Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccinesSteven A Rosenberg, Richard M Sherry, Kathleen E Morton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancerNachimuthu Chinnasamy, Jennifer A Wargo, Zhiya Yu, et al.
Journal of Leukocyte Biology|May 25, 2004
Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancerSteven E Finkelstein, David M Heimann, Christopher A Klebanoff, et al.
Cellular & Molecular Immunology|April 28, 2015
Lineage relationship of CD8(+) T cell subsets is revealed by progressive changes in the epigenetic landscapeJoseph G Crompton, Manikandan Narayanan, Suresh Cuddapah, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigensGiao Q Phan, Christopher E Touloukian, James C Yang, et al.
Vaccine|December 3, 2014
Transcriptional profiles reveal a stepwise developmental program of memory CD8(+) T cell differentiationRahul Roychoudhuri, Francois Lefebvre, Mitsuo Honda, et al.
Nature Communications|December 24, 2016
Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis inductionAnthony C Cruz, Madhu Ramaswamy, Claudia Ouyang, et al.
Pageof 26

Showing results (171-180 of 260) with videos related to

Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccinesFranz O Smith, Stephanie G Downey, Jacob A Klapper, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2008
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunityDouglas C Palmer, Chi-Chao Chan, Luca Gattinoni, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2004
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cellsChristopher A Klebanoff, Steven E Finkelstein, Deborah R Surman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 15, 2006
Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccinesSteven A Rosenberg, Richard M Sherry, Kathleen E Morton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancerNachimuthu Chinnasamy, Jennifer A Wargo, Zhiya Yu, et al.
Journal of Leukocyte Biology|May 25, 2004
Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancerSteven E Finkelstein, David M Heimann, Christopher A Klebanoff, et al.
Cellular & Molecular Immunology|April 28, 2015
Lineage relationship of CD8(+) T cell subsets is revealed by progressive changes in the epigenetic landscapeJoseph G Crompton, Manikandan Narayanan, Suresh Cuddapah, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigensGiao Q Phan, Christopher E Touloukian, James C Yang, et al.
Vaccine|December 3, 2014
Transcriptional profiles reveal a stepwise developmental program of memory CD8(+) T cell differentiationRahul Roychoudhuri, Francois Lefebvre, Mitsuo Honda, et al.
Nature Communications|December 24, 2016
Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis inductionAnthony C Cruz, Madhu Ramaswamy, Claudia Ouyang, et al.
Pageof 26